Long
Small account play with potential upcoming COVID catalyst

Vaccine play: “Four vaccine candidates developed from VXRT's proprietary VAAST platform were assessed in mouse models and elicited a strong immune response.” (finance.yahoo.com/news/advantage-vaxart-sharp-pullback-says-200653838.html)
Fib targets above, can use 0 fib below for stop loss.
- Potential upcoming catalyst of a Phase 1 trial
As of last week, down 73% since the yearly high, has begun to reverse.
Very oversold on SlowStoch and has been for nearly a month
Below 100day SMA, only slightly above 200day SMA
Fib targets above, can use 0 fib below for stop loss.
Trade chiuso: obiettivo raggiunto
Even as a late add this was a big winner.Trade attivo
Re-entered, but chasing slightly. Hoping for a break to 9.47 and above.Tools for traders and investors smart enough to keep it simple.
TheStrat Suite is now free & open source 😘👌 TheStratSuite.com
Build on it: github.com/natebking/345-strategies
Everything else: 345strategies.com
TheStrat Suite is now free & open source 😘👌 TheStratSuite.com
Build on it: github.com/natebking/345-strategies
Everything else: 345strategies.com
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Tools for traders and investors smart enough to keep it simple.
TheStrat Suite is now free & open source 😘👌 TheStratSuite.com
Build on it: github.com/natebking/345-strategies
Everything else: 345strategies.com
TheStrat Suite is now free & open source 😘👌 TheStratSuite.com
Build on it: github.com/natebking/345-strategies
Everything else: 345strategies.com
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.